Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non‐expressors early after living donor kidney transplantation: Effect of interleukin 6–induced suppression of the cytochrome P450 3A gene-Reference-Cited by-同舟云学术

Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non‐expressors early after living donor kidney transplantation: Effect of interleukin 6–induced suppression of the cytochrome P450 3A gene

Published:2020-12-12 Issue:3 Volume:128 Page:525-533
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin. Pharmacol. Toxicol.

Author:

Enokiya Tomoyuki¹^ORCID,Nishikawa Kohei²,Hamada Yugo³,Ikemura Kenji³^ORCID,Sugimura Yoshiki²,Okuda Masahiro³⁴

Affiliation:

1. Laboratory of Pharmacoinformatics Department of Pharmaceutical Sciences Suzuka University of Medical Science Suzuka Japan

2. Department of Nephro‐Urologic Surgery and Andrology Mie University Graduate School of Medicine Tsu Japan

3. Department of Clinical Pharmacy and Biopharmaceutics Mie University Graduate School of Medicine Tsu Japan

4. Department of Pharmacy Osaka University Hospital Suita Japan

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13539

Reference25 articles.

1. KDIGO clinical practice guideline for the care of kidney transplant recipients;Kidney Disease: Improving Global Outcomes Transplant Work G;Am J Transplant.,2009

2. Tacrolimus, a New Immunosuppressant—A Review of the Literature

3. A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients

4. Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups*

5. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of IL-6 and IL-10 genotypes on tacrolimus dose requirements in kidney transplant recipients: Monte Carlo analysis;Pharmacogenomics;2024-05-02

2. Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration;Journal of Pharmaceutical Health Care and Sciences;2023-12-04

3. Model-Informed Estimation of Acutely Decreased Tacrolimus Clearance and Subsequent Dose Individualization in a Pediatric Renal Transplant Patient With Posterior Reversible Encephalopathy Syndrome;Therapeutic Drug Monitoring;2023-01-10

4. The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy;Frontiers in Pharmacology;2022-02-02

5. CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients;Scientific Reports;2021-11-01